Patents
Literature
2 results about "Anti cd19" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Combination of anti CD19 antibody with a BCL-2 inhibitor and uses thereof
PendingUS20260176355A1Organic active ingredientsPharmaceutical delivery mechanismAntiendomysial antibodiesPharmacy medicine
The present disclosure describes a pharmaceutical combination of an anti-CD19 antibody and a BCL-2 inhibitor for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia and / or acute lymphoblastic leukemia.
Owner:INCYTE CORP
Novel bispecific anti CD19-CD20 car-t constructs and uses thereof
PCT designated stageWO2026131594A1Immunoglobulins against cell receptors/antigens/surface-determinantsAntineoplastic agentsCD20Autoimmune condition
The present disclosure provides CD19 / CD20-binding domains and chimeric antigen receptors (CARs) based on the same, as well as corresponding nucleic acid molecules, vectors, cells, compositions, methods and uses, e.g., for the prevention and / or treatment of cancer and / or autoimmune disease.
Owner:LAKEFRONT BIOTHERAPEUTICS NV